Please select the option that best describes you:
When in the treatment algorithm for pancreatic/GI NET do you recommend interferon?
Answer from: Medical Oncologist at Academic Institution
Our team uses interferon only occasionally and generally later in the algorithm. With randomized data to support agents with favorable toxicity profiles, such as somatostatin analogues, everolimus, and PRRT, these options are frequently preferable.However, older randomized data (Kolby et al., Br J ...
Sign in or Register to read more